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Some years ago when I was asked to write a review
of a particular field, I protested that very little was
known on the subject. The Editor, much wiser than
I, made it clear that he felt that made it an ideal
topic for review. The problem with most reviews is
that they are often written when the subject to be
reviewed has grown to the point where it is getting
difficult for all aspects to be within the compass of
a single mind. That is not always a fatal flaw,
however, since a review may be of value not
because of the detail it contains but because of the
framework within which it is written or because it
comes at a moment in time when it is appropriate
to be reminded of certain facts.
Advances in Cancer Research has been for many
years not only an invaluable reference source but
also a source of varied reviews which fall into
several of the categories outlined above. The
current volume is no exception. The article on
concomitant tumour immunity by E. Gorelik comes
into the "timely reminder" category. There are
many phenomena associated with tumour growth
for which we still have no adequate explanation,
for example, the phenomenon of concomitant
tumour immunity strongly supports the concept of
an immune response to cancer but the stimulation
of the growth of metastases following excision of
the primary tumour does not fit comfortably with
conventional notions of immunity. Two superb
articles on polyoma virus by Beverly Griffin and
Stephen Dilworth and on oncogenic avian
retroviruses by Paula Enrietto and John Wyke are
both timely and impressive in the wide range of
informa-tion presented in a most readable form in
spite of considerable detail. If one wishes to catch
up on the current status of transformation by DNA
viruses and by RNA retrovirsuses and brush up on
oncogenes at the same time it is all here. A short
piece on adjuvant chemotherapy of solid tumours
by David Berstock and Michael Baum confirmed a
pre-conceived impression that results so far are not
encouraging. I have to admit I found the review of
neoplastic development in airway epithelium by P.
Nettesheim and A. Marchok rather heavy going.
The authors, to be fair, achieve what they set out
to do, namely to concentrate fairly narrowly and in
considerable detail on the process of development
of neoplastic foci. For specialists, I imagine, this
would be valuable but those from other fields may
share my reaction. I have somewhat similar feelings
about the study of antigenic variation induced by
mutagens in tumour cells by Thierry Boon. It is, of
course, interesting to know that non-tumourigenic
variants of transplantable tumour cell lines can be
induced by mutagen treatment, but not altogether a
surprise. Even less surprising is the
acknowledgement by the author that results of such
studies may be hard to apply to human tumour
immunotherapy. The chapter by Dorothy Miller
and Jack Miller on tumours of the mouse
established cell lines and cell hybrids is an excellent
example of how a field can be reviewed concisely
and with clarity. It ranges from straight cyto-
genetics through the suppression of malignancy by
hybridization to the role of specific gene loci in
malignant transformation; it is a most useful back-
ground against which to consider many of the
interesting molecular phenomena which are
currently emerging.
This is a very interesting volume for the
experimentalist rather than for the clinician but
nevertheless of wide interest for anyone involved in
the field of cancer research.
D.G. Harnden
Paterson Laboratories,
Christie Hospital & Holt Radium Institute,
Manchester.
The dynamic body tissues. W.S. BULLOUGH, U.K.,
MTP Press Limited,181 pp, 1983, £17.95.
ISBN 0 85200 415.
Professor Bullough (recently retired) has for long
been the chief driving force behind the chalone
movement. This book sets out to describe the
mechanics of the body tissues in terms of chalone
action, with all other regulatory mechanisms
relegated, at best, to a secondary role. Finally,
chalone is seen both as a factor in the development
of, and the answer to, cancer. This is not to say
that the ideas presented should be dismissed out of
hand. The principle of feedback regulation, whether
by direct inhibition of cell proliferation or by
suppression of proliferation stimulators, is clearly
operative in the body tissues and due consideration
should be given to the principles suggested here.
The manner in which they are presented, however,
leaves much to be desired. Authoritative statements
are made without justification or reference; e.g.,
"The evidence that it is chalone is now
H